Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron for Treatment of Postoperative Nausea and Vomiting
NCT01568268Phase 3Completed
- Sponsor
- Samsung Medical Center
- Start
- Jan 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of palonosetron in postoperative nausea and vomiting (PONV), sponsored by Samsung Medical Center. Started Jan 2012; status: completed.
02
Drugs
palonosetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01568268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568268.